• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YY1在分化型甲状腺癌中的表达

Expression of YY1 in Differentiated Thyroid Cancer.

作者信息

Arribas Jéssica, Castellví Josep, Marcos Ricard, Zafón Carles, Velázquez Antonia

机构信息

Grup de Mutagènesi, Unitat de Genètica, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallés, Barcelona, Spain.

出版信息

Endocr Pathol. 2015 May;26(2):111-8. doi: 10.1007/s12022-015-9359-6.

DOI:10.1007/s12022-015-9359-6
PMID:25698133
Abstract

The transcription factor Yin Yang 1 (YY1) has an important regulatory role in tumorigenesis, but its implication in thyroid cancer has not been yet investigated. In the present study, we have analyzed the expression of YY1 in differentiated thyroid cancer and assessed the association of YY1 expression with clinical features. Expression of YY1 was evaluated in human thyroid cancer cell lines, a series of matched normal/tumor thyroid tissues and in a thyroid cancer tissue microarray, using real-time PCR, Western blot, and/or immunohistochemistry. YY1 was overexpressed in thyroid cancer cells, at transcription and protein levels. A significant increase of YY1 mRNA was also observed in tumor thyroid tissues. Moreover, immunohistochemical analysis of the thyroid cancer tissue microarray revealed that both papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC) present increased YY1 protein levels (48 and 19%, respectively). After stratification by the level of YY1 protein, positive YY1 expression identifies 88% of patients with PTC. The association of YY1 expression with clinicopathological features in PTC and FTC showed that YY1 expression was related with age at diagnosis. Our data indicates for the first time overexpression of YY1 in differentiated thyroid cancer, with YY1 being more frequently overexpressed in the PTC subtype.

摘要

转录因子阴阳1(YY1)在肿瘤发生过程中发挥着重要的调控作用,但其在甲状腺癌中的作用尚未得到研究。在本研究中,我们分析了YY1在分化型甲状腺癌中的表达情况,并评估了YY1表达与临床特征之间的关联。我们采用实时定量聚合酶链反应、蛋白质免疫印迹法和/或免疫组织化学法,对人甲状腺癌细胞系、一系列配对的正常/肿瘤甲状腺组织以及一个甲状腺癌组织芯片中YY1的表达进行了评估。YY1在甲状腺癌细胞的转录水平和蛋白质水平均呈过表达状态。在肿瘤甲状腺组织中也观察到YY1信使核糖核酸显著增加。此外,对甲状腺癌组织芯片进行免疫组织化学分析显示,甲状腺乳头状癌(PTC)和甲状腺滤泡状癌(FTC)中YY1蛋白水平均升高(分别为48%和19%)。根据YY1蛋白水平进行分层后,YY1阳性表达可识别出88%的PTC患者。YY1表达与PTC和FTC临床病理特征之间的关联表明,YY1表达与诊断时的年龄有关。我们的数据首次表明YY1在分化型甲状腺癌中过表达,且在PTC亚型中YY1过表达更为常见。

相似文献

1
Expression of YY1 in Differentiated Thyroid Cancer.YY1在分化型甲状腺癌中的表达
Endocr Pathol. 2015 May;26(2):111-8. doi: 10.1007/s12022-015-9359-6.
2
DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.DUSP6/MKP3 在甲状腺乳头状癌和低分化甲状腺癌中过表达,并促进甲状腺癌细胞的肿瘤特性。
Endocr Relat Cancer. 2013 Jan 21;20(1):23-37. doi: 10.1530/ERC-12-0078. Print 2013 Feb.
3
Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis.胚胎形态发生素Nodal在分化型甲状腺癌中的表达:组织芯片免疫组化检测及癌症基因组图谱数据分析
Surgery. 2014 Dec;156(6):1559-67; discussion 1567-8. doi: 10.1016/j.surg.2014.08.050. Epub 2014 Nov 11.
4
Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.间变性甲状腺癌中转录延伸因子A(SII)样4(TCEAL4)的下调
BMC Cancer. 2006 Nov 1;6:260. doi: 10.1186/1471-2407-6-260.
5
Stomatin-like protein 2 is associated with the clinicopathological features of human papillary thyroid cancer and is regulated by TGF-β in thyroid cancer cells.基质蛋白 2 与人类甲状腺乳头状癌的临床病理特征相关,并受甲状腺癌细胞中 TGF-β 的调节。
Oncol Rep. 2014 Jan;31(1):153-60. doi: 10.3892/or.2013.2833. Epub 2013 Nov 4.
6
Transcription factor YY1 expression in human gastrointestinal cancer cells.转录因子YY1在人胃肠道癌细胞中的表达。
Int J Oncol. 2009 May;34(5):1417-23.
7
Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.甲状腺间变性癌更多地起源于滤泡癌而非乳头状癌。
Ann Surg Oncol. 2007 Oct;14(10):3011-8. doi: 10.1245/s10434-007-9503-8. Epub 2007 Jul 20.
8
Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor.分化型甲状腺癌中线粒体DNA突变与年龄因素的关系。
World J Surg. 2007 Jan;31(1):51-9. doi: 10.1007/s00268-005-0447-5.
9
Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.bcl-2、c-erbB-2、p53和p21(waf1-cip1)蛋白在甲状腺癌中的表达
J Exp Clin Cancer Res. 1999 Sep;18(3):363-7.
10
Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?微 RNA 特征能否区分具有不确定恶性潜能的甲状腺肿瘤和其他分化良好的甲状腺肿瘤?
Endocr Relat Cancer. 2011 Sep 13;18(5):579-94. doi: 10.1530/ERC-10-0283. Print 2011 Oct.

引用本文的文献

1
Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions.靶向转录因子YY1用于癌症治疗:当前策略与未来方向
Cancers (Basel). 2023 Jul 5;15(13):3506. doi: 10.3390/cancers15133506.
2
Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto's thyroiditis using bioinformatics methods.运用生物信息学方法鉴定和分析甲状腺乳头状癌和桥本甲状腺炎的共有关键基因。
Front Endocrinol (Lausanne). 2023 May 31;14:1140094. doi: 10.3389/fendo.2023.1140094. eCollection 2023.
3
circSOX4 Enhances Hepatocellular Carcinoma Progression via miR-218-5p/YY1 Signaling.

本文引用的文献

1
Integrated genomic characterization of papillary thyroid carcinoma.甲状腺乳头状癌的综合基因组特征分析
Cell. 2014 Oct 23;159(3):676-90. doi: 10.1016/j.cell.2014.09.050.
2
Promoter-region hypermethylation and expression downregulation of Yy1 (Yin yang 1) in preneoplastic liver lesions in a thioacetamide rat hepatocarcinogenesis model.硫代乙酰胺诱导的大鼠肝癌发生模型中癌前肝损伤中Yy1(阴阳1)启动子区域高甲基化及表达下调
Toxicol Appl Pharmacol. 2014 Nov 1;280(3):467-74. doi: 10.1016/j.taap.2014.08.013. Epub 2014 Aug 22.
3
DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
环状 RNA Sox4 通过 miR-218-5p/YY1 信号增强肝癌进展。
Biomed Res Int. 2023 Apr 25;2023:3370440. doi: 10.1155/2023/3370440. eCollection 2023.
4
Hypermethylation of microRNA-497-3p contributes to progression of thyroid cancer through activation of PAK1/β-catenin.miR-497-3p 高甲基化通过激活 PAK1/β-catenin 促进甲状腺癌的进展。
Cell Biol Toxicol. 2023 Oct;39(5):1979-1994. doi: 10.1007/s10565-021-09682-1. Epub 2022 Jan 23.
5
YY1 Promotes Telomerase Activity and Laryngeal Squamous Cell Carcinoma Progression Through Impairment of GAS5-Mediated p53 Stability.YY1 通过损害 GAS5 介导的 p53 稳定性促进端粒酶活性和喉鳞状细胞癌进展。
Front Oncol. 2021 Aug 23;11:692405. doi: 10.3389/fonc.2021.692405. eCollection 2021.
6
Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort.泛癌队列中SENP1的组学、免疫浸润和药物基因组学证据。
Front Pharmacol. 2021 Jul 1;12:700454. doi: 10.3389/fphar.2021.700454. eCollection 2021.
7
The biological implications of Yin Yang 1 in the hallmarks of cancer.阴阳 1 在癌症标志中的生物学意义。
Theranostics. 2020 Mar 4;10(9):4183-4200. doi: 10.7150/thno.43481. eCollection 2020.
8
Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.基于网络的遗传分析揭示滤泡性甲状腺癌和滤泡状甲状腺腺瘤之间的细胞通路差异。
Int J Environ Res Public Health. 2020 Feb 20;17(4):1373. doi: 10.3390/ijerph17041373.
9
The Two Sides of YY1 in Cancer: A Friend and a Foe.YY1在癌症中的两面性:既是朋友又是敌人。
Front Oncol. 2019 Nov 20;9:1230. doi: 10.3389/fonc.2019.01230. eCollection 2019.
10
miR-544 inhibits the migration and invasion of anaplastic thyroid cancer by targeting Yin Yang-1.微小RNA-544通过靶向阴阳-1抑制间变性甲状腺癌的迁移和侵袭。
Oncol Lett. 2019 Mar;17(3):2983-2992. doi: 10.3892/ol.2019.9915. Epub 2019 Jan 9.
对分化型甲状腺癌进行 DNA 甲基化谱分析,揭示了无复发生存的标志物。
Int J Cancer. 2014 Aug 1;135(3):598-610. doi: 10.1002/ijc.28703. Epub 2014 Jan 13.
4
Management of regional nodes in thyroid cancer.甲状腺癌区域淋巴结的处理。
Oral Oncol. 2013 Jul;49(7):671-5. doi: 10.1016/j.oraloncology.2013.03.441. Epub 2013 Apr 9.
5
Prognostic value of epidermal growth factor receptor, p53 and galectin-3 expression in papillary thyroid carcinoma.表皮生长因子受体、p53和半乳糖凝集素-3表达在甲状腺乳头状癌中的预后价值
J Int Med Res. 2013 Jun;41(3):825-34. doi: 10.1177/0300060513477312. Epub 2013 Mar 28.
6
Molecular pathogenesis and mechanisms of thyroid cancer.甲状腺癌的分子发病机制及机制。
Nat Rev Cancer. 2013 Mar;13(3):184-99. doi: 10.1038/nrc3431.
7
Signaling pathways in follicular cell-derived thyroid carcinomas (review).滤泡细胞来源的甲状腺癌中的信号通路(综述)。
Int J Oncol. 2013 Jan;42(1):19-28. doi: 10.3892/ijo.2012.1681. Epub 2012 Oct 29.
8
Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008.增强检测对美国甲状腺癌发病率增长的影响:对监测、流行病学和最终结果登记处 1980-2008 年间按社会经济地位划分的发病率趋势的审查。
Thyroid. 2013 Jan;23(1):103-10. doi: 10.1089/thy.2012.0392.
9
Thyroid cancer: molecular aspects and new therapeutic strategies.甲状腺癌:分子层面与新治疗策略
J Thyroid Res. 2012;2012:847108. doi: 10.1155/2012/847108. Epub 2012 Jul 12.
10
A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry.基于监测、流行病学和最终结果(SEER)登记处,对美国癌症联合委员会(AJCC)用于年轻分化型甲状腺癌患者的分期系统进行批判性分析。
Surgery. 2012 Aug;152(2):145-51. doi: 10.1016/j.surg.2012.02.015. Epub 2012 Apr 11.